DUBLIN, Feb 17, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the
"Nanobiotechnology - Global Strategic Business Report" report to
their offering.
The report provides separate comprehensive analytics for the US,
Japan, Europe, and Rest of World. Annual estimates
and forecasts are provided for the period 2015 through 2022. Also,
a six-year historic analysis is provided for these markets. Market
data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Nanobiotechnology in
US$ Million.
Companies Profiled:
- Ablynx NV (Belgium)
- Arrowhead Pharmaceuticals, Inc. (USA)
- Avadel Pharmaceuticals plc (Ireland)
- CaPtivate Pharmaceuticals LLC (USA)
- Celgene Corporation (USA)
- ELITechGroup (France)
- GlaxoSmithKline Plc. (UK)
- Johnson & Johnson (USA)
- Merck & Co., Inc. (USA)
- NanoBio® Corporation (USA)
- Nanophase Technologies Corporation (USA)
- pSivida Corp. (USA)
- Sigma-Aldrich Corp. (USA)
- Starpharma Holdings Ltd. (Australia)
- Vectura Group plc (UK) Key Topics Covered:
1. INDUSTRY OVERVIEW
2. COMPETITIVE SCENARIO
3. MARKET DYNAMICS
Developing Countries to Rise over the Horizon
Nanomaterials & Nanoparticles Witness Robust Activity
Focus on Improved Performance to Bring New Manufacturing Methods
for Nanomaterials
Why Invest in Nanobiotechnology?
Private and Public Companies to Step Up Funding on
Nanotechnology
United States Lead the Way in Government Funding
Increasing Awareness on Technology to Drive Growth
Demand for Novel Products to Push Up Growth
Nano-Enabled Drug Discovery Holds Tremendous Potential
Consolidation Sharpens the Industry's Edge
4. INDUSTRY CHALLENGES & ISSUES
5. INDUSTRY STRUCTURE
6. NANOBIO'S EPOCHAL STRIDES IN MODERN MEDICINE
7. INNOVATIONS & ADVANCEMENTS
8. CONCEPTUAL OVERVIEW
9. GLOBAL RESEARCH CENTERS AND INSTITUTIONS
10. RECENT INDUSTRY ACTIVITY
Vectura Group Inks Merger Agreement with Skyepharma Flamel
Technologies to Merge with Avadel Pharmaceuticals
Pfizer to Acquire BIND Therapeutics Assets Janssen Sciences
Ireland Enters into Collaboration with ViiV Healthcare
Tekna Holdings Canada Inks Agreement with National Research Council of Canada Roche and
BioMed X Sign a Collaboration Agreement
Ablynx Enters into Exclusive Research Collaboration with
Genzyme
Pfizer Exercises Option to Develop and Commercialize Accurin
BIND Therapeutics Inks Joint Research and Development Agreement
with Merck
11. FOCUS ON SELECT GLOBAL PLAYERS
12. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 79
The United States (49)
Canada (2)
Japan (1)
Europe (19)
- France (2)
- Germany (6)
- The United Kingdom (4)
- Rest of Europe (7)
Asia-Pacific (Excluding Japan)
(5)
Middle East (3)
For more information about this report visit
http://www.researchandmarkets.com/research/hdjs9m/nanobiotechnology
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716